Fonar Corp updates earnings schedule, shares on NASDAQ radar
22.06.2026 - 21:04:16 | ad-hoc-news.de
By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-22, 20:59.
Fonar Corp (US3444371021) is lining up its next earnings report on Nasdaq, with investors watching the small-cap MRI specialist alongside larger peers GE HealthCare and Siemens Healthineers. Market data providers list the upcoming quarterly update in the second half of 2026 based on the company’s regular reporting cycle.
What the calendar shows
Fonar last reported quarterly numbers for its fiscal 2025/2026 cycle earlier this year, with the next earnings date indicated for late summer 2026 on several earnings-calendar services. These calendars typically track Fonar under its Nasdaq ticker FONR alongside other US healthcare names. Nasdaq’s earnings overview for FONR highlights the historical sequence of prior quarterly releases.
Consensus data for the stock remain sparse as Fonar is followed by only a few specialist healthcare analysts, in contrast to large-cap peers such as GE HealthCare and Siemens Healthineers that attract broader Wall Street coverage. MarketScreener and similar platforms nevertheless aggregate available per-share estimates and revenue projections for the coming quarters. MarketScreener’s Fonar estimates page summarizes the current forecasts.
Analysts and peer comparison
Whereas S&P 500 healthcare equipment stocks like GE HealthCare or diagnostic imaging rival Siemens Healthineers often see more than a dozen active ratings, Fonar typically features only a handful of formal recommendations on aggregator platforms. Those available tend to describe the shares as a niche play on MRI scanning technology within the US diagnostic market.
Fonar’s market capitalization places it well below the billion-dollar threshold, which limits its inclusion in major indices such as the S&P 500 or NASDAQ-100. Instead, the company trades solely on Nasdaq’s main market, with liquidity driven by specialist healthcare investors rather than broad index flows.
All news and background on the Fonar Corp shares
Further price data, historical earnings and corporate news on Fonar Corp are available in the dedicated topic area on ad-hoc-news.de and via the company’s investor relations page.
The product behind the stock
Fonar generates revenue primarily from its Upright MRI scanners and related diagnostic imaging services. The Upright MRI system allows patients to be scanned in weight-bearing positions, including standing or sitting, which can provide additional clinical information for spine and joint assessments compared with traditional supine-only MRI systems.
Where the stock trades today
Fonar Corp shares (US3444371021) last traded on Nasdaq at around 19.11 US dollars in pre-market indications on 2026-06-22, according to trading platform data at 09:30 Eastern Time. This price level reflects the company’s status as a small-cap US healthcare equipment issuer.
Key data on the Fonar Corp shares
- Company: Fonar Corporation
- ISIN: US3444371021
- WKN: 885990
- Ticker: FONR
- Trading venue: NASDAQ
- Price (as of 2026-06-22, 09:30): 19.11 USD
- Market cap: around 0.13 billion USD (as of 2026-06-22)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: not included in major indices such as S&P 500 or NASDAQ-100
- Next earnings date: expected in the second half of 2026 based on historical reporting pattern
Disclaimer: This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities. Readers should conduct their own research or consult a qualified financial advisor before making investment decisions.
